June 2001 saw the launch of AstraZeneca's new respiratory brand

In the summer of 2002 the Symbicort campaign took a dramatic new direction.

In the Spring of 2003, Symbicort obtained its COPD licence. Given the link between the condition and smoking, it seemed appropriate to used a parody of cigarette advertising to promote it